Omron推出VP系列产品早期诊断心血管疾病

 
一种新型非创伤性血管横向全面调节器系统，与当前美国心脏病学学院(ACC)和美国心脏学会(AHA)合作的外周动脉疾病(PAD)治疗指南合作，能够测定脚踝上臂指数(ABI)、脉搏波形速率(PWV)以及增压指数。

按照高新技术标准进行设计的VP-系列系统是由Omron医疗保健公司(Bannockburn, IL, USA)开发的，能够为医生提供精确而简洁的非创伤性工具，对心血管疾病进行诊断和处理。对心血管疾病的早期诊断能够帮助医生更早更有效地处理患者，从而改善患者的生存质量。VP-系列产品使用获得保护的波形分析和血管评估(WAVE)技术，能够得到更加精确的结果。VP-系列产品包括VP-1000和功能更强的姐妹产品VP-2000。

 
Vascular Profiler Diagnoses Heart Disease
 
A new non-invasive vascular profiling system, in alignment with the current American College of Cardiology (ACC) and American Heart Association (AHA) guidelines on peripheral arterial disease (PAD) management, is capable of measuring ankle brachial index (ABI), pulse wave velocity (PWV), and augmentation index (AI).

Designed with advanced technology, the VP-Series system, developed by Omron Healthcare, Inc. (Bannockburn, IL, USA), provides physicians with accurate and easy-to-use non-invasive tools for cardiovascular disease diagnosis and management. Early detection of cardiovascular disease will enable physicians to treat patients earlier and more efficiently, thereby improving patient quality of life. The VP-Series uses patented waveform analysis and vascular evaluation (WAVE) technology to enable accurate results to achieve this goal. The VP-Series includes the VP-1000 and its more enhanced sister version, the VP- 2000.